Paradia, Lea G.
HRN: 14-22-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/06/2025
12/13/2025
IV
500MG
Q8HRS
T/C ACUTE SURGICAL ABDOMEN PROBABLY SECONDARY TO RUPTURED APPENDICITIS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes